Form 4 Tracker
Brent Sabatini

SVP, Chief Accounting Officer · 5 filings · Latest: Jun 1, 2026

Vir Biotechnology, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
VIR
Brent SabatiniSVP, Chief Accounting OfficerJun 1, 2026
Sale
$9.45379$3.6K61,902
VIR
Sabatini Brent—Jun 1, 2026
Proposed Sale
$9.45379$3.6K—
VIR
Brent SabatiniSVP, Chief Accounting OfficerMar 23, 2026
Sale
$9.127,711$70.3K61,902
VIR
Sabatini Brent—Mar 23, 2026
Proposed Sale
$9.127,711$70.3K—
VIR
Brent SabatiniSVP, Chief Accounting OfficerFeb 24, 2026
Sale
$9.531,430$13.6K69,613
VIR
Brent SabatiniSVP, Chief Accounting OfficerFeb 23, 2026
Sale
$7.451,829$13.6K71,043
VIR
Sabatini Brent—Feb 24, 2026
Proposed Sale
$9.531,430$13.6K—
VIR
Sabatini Brent—Feb 23, 2026
Proposed Sale
$7.451,829$13.6K—
VIR
Brent SabatiniSVP, Chief Accounting OfficerFeb 13, 2026
Sale
$7.791,530$11.9K47,872
VIR
Sabatini Brent—Feb 13, 2026
Proposed Sale
$7.791,530$11.9K—
VIR
Brent Sabatini—Feb 24, 2025
Proposed Sale
$9.451,562$14.8K—
VIR
Brent Sabatini—Feb 13, 2025
Proposed Sale
$9.151,562$14.3K—